ASSESSMENT TO THE COMPLIANCE ON GOOD GOVERNANCE OF MEDICINES IN THE PHARMACEUTICAL SECTOR

Abstract

ABSTRACT This report presents the results of transparency assessments carried out in Rwanda. It provides a comprehensive picture of the level of transparency and the potential vulnerability to corruption of four selected functions of the pharmaceutical sector which are Selection of medicines, Registration of medicines, Procurement and distribution of medicines. The methodology provides both qualitative and quantitative information. The data were collected data by conducting a series of interviews with carefully selected key informants. The information collected was then converted using a rough quantification method into a zero to 10 scales, to provide a score for each function in terms of vulnerability to corruption (minimal to extreme). The scoring indicates vulnerability in terms of the policy, the regulatory and administrative structures and the procedures at the time of the survey. The quantitative data reveals that the selection and Registration of medicines are both moderately vulnerable to the corruption; the medicines procurement received the highest scores and is minimally vulnerable to corruption; while distribution of medicines is marginally vulnerable to the corruption. In summary, the findings and methodology that this study introduces can help health specialists and government decision makers prioritize those areas in the pharmaceutical system, which need the highest investment and regulation. This information, in turn, helps to ensure that investments in the pharmaceutical system are maximized and that access to essential medicines is improved.